FGAM
HRMY icon

Financial Gravity Asset Management’s Harmony Biosciences HRMY Stock Holding History

Financial Gravity Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33
Closed -$1.55K – 1718
2023
Q1 		$1.55K Sell
33
-22
-40% -$1K 0.05% 326
2022
Q4 		$774 Sell
55
-649
-92% -$35.7K ﹤0.01% 718
2022
Q3 		$2.23K Buy
+704
New +$34.3K 0.08% 261

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Financial Gravity Asset Management's HRMY Position: Q2 2023 in Review

Financial Gravity Asset Management sold out of Harmony Biosciences (HRMY) in Q2 2023, closing a stake of 33 shares — an estimated $1.55K sold.

Financial Gravity Asset Management first reported a position in HRMY in Q3 2022 and held it in 3 quarters. The position peaked at $2.23K in Q3 2022. 211 funds tracked by Wall St. Rank hold HRMY as of Q2 2023.

  • Financial Gravity Asset Management reported no remaining Harmony Biosciences position as of Q2 2023 after selling out during the quarter.
  • Financial Gravity Asset Management sold 33 Harmony Biosciences shares in Q2 2023, an estimated $1.55K.
  • Financial Gravity Asset Management first reported a position in Harmony Biosciences in Q3 2022 and held it in 3 quarters.
  • Financial Gravity Asset Management's Harmony Biosciences position peaked at $2.23K in Q3 2022.
  • 211 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2023.

Based on Financial Gravity Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.